Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain.
Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain.
复制标题
DOI:
10.1016/j.neuroimage.2013.06.066
复制
发表时间:
2013-12
期刊:
影响因子:
5.7
通讯作者:
Blankenberg, Francis
中科院分区:
文献类型:
--
作者:
D'Arceuil, Helen;Coimbra, Alexandre;Triano, Pamela;Dougherty, Margaret;Mello, Julie;Moseley, Michael;Glover, Gary;Lansberg, Maarten;Blankenberg, Francis
The brain demonstrates spontaneous low-frequency (< 0.1 Hz) cerebral blood flow (CBF) fluctuations, measurable by resting-state functional MRI (rs-fMRI). Ultra small superparamagnetic iron oxide particles have been shown to enhance task-based fMRI signals (cerebral blood volume fMRI or CBV-fMRI), compared to the BOLD effect, by a factor of ≈ 2.5 at 3T in primates and humans. We evaluated the use of ferumoxytol for steady state,resting state FMRI (CBV-rs-fMRI) and relative cerebral blood volume (rCBV) mapping, at 3 Tesla, in healthy volunteers. All standard resting state networks (RSNs) were identified in all subjects.On average the RSN Z-statistics(Melodic independent components)and volumes of the Visual and default mode (DMN)networks were comparable rCBV values were averaged forthe visual (Vis) and DMN networks and correlated with the corresponding DMN and Visual network Z statistics. There was a negative correlation between the rCBV and the Z-statisticsforthe DMN, for both BOLD and CBVrs-fMRI contrast (R2= 0.63, 0.76).A similar correlation was not found for the visual network. Short repetition time rs-fMRI data were Fourier transformed to evaluate the effect of ferumoxytol on cardiac and respiratory fluctuations in the brain rs-BOLD, CBV signals. Cardiac and respiratory fluctuations decreased to baseline within large vessels post ferumoxytol.Robust rs-fMRI and CBV mapping is possible in normal human brain.
登录
查看更多内容
影响因子:
5.7
作者:
Jenkinson, M;Bannister, P;Smith, S
通讯作者:
Smith, S
影响因子:
3.7
作者:
Stamatakis EA;Adapa RM;Absalom AR;Menon DK
通讯作者:
Menon DK
影响因子:
3.7
作者:
Shirer, W. R.;Ryali, S.;Greicius, M. D.
通讯作者:
Greicius, M. D.
影响因子:
4.8
作者:
Birn, Rasmus M.;Murphy, Kevin;Bandettini, Peter A.
通讯作者:
Bandettini, Peter A.
DOI:
10.1098/rstb.2005.1634
发表时间:
2005-05-29
影响因子:
6.3
作者:
Beckmann, CF;DeLuca, M;Smith, SM
通讯作者:
Smith, SM